81 FR 76626 - Certain Radiotherapy Systems and Treatment Planning Software, and Components Thereof; Notice of Request for Statements on the Public Interest

INTERNATIONAL TRADE COMMISSION

Federal Register Volume 81, Issue 213 (November 3, 2016)

Notice is hereby given that the presiding administrative law judge (``ALJ'') has issued a recommended determination on remedy and bonding in the above-captioned investigation. The Commission is soliciting submissions from the public on any public interest issues raised by the recommended relief. The ALJ recommended that a limited exclusion order issue against certain radiotherapy systems and treatment planning software, and components thereof, imported by respondents Elekta AB of Stockholm, Sweden; Elekta Ltd. of Crawley, United Kingdom; Elekta GmbH of Hamburg, Germany; Elekta Inc. of Atlanta, Georgia; IMPAC Medical Systems, Inc. of Sunnyvale, California; Elekta Instrument (Shanghai) Limited of Shanghai, China; and Elekta Beijing Medical Systems Co. Ltd. of Beijing, China (collectively, ``Elekta''). The ALJ also recommended that cease and desist orders be directed to Elekta. Parties are to file public interest submissions pursuant to 19 CFR 210.50(a)(4).

[Federal Register Volume 81, Number 213 (Thursday, November 3, 2016)]
[Notices]
[Pages 76626-76627]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-26602]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-968]


Certain Radiotherapy Systems and Treatment Planning Software, and 
Components Thereof; Notice of Request for Statements on the Public 
Interest

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the presiding administrative law 
judge (``ALJ'') has issued a recommended determination on remedy and 
bonding in the above-captioned investigation. The Commission is 
soliciting submissions from the public on any public interest issues 
raised by the recommended relief. The ALJ recommended that a limited 
exclusion order issue against certain radiotherapy systems and 
treatment planning software, and components thereof, imported by 
respondents Elekta AB of Stockholm, Sweden; Elekta Ltd. of Crawley, 
United Kingdom; Elekta GmbH of Hamburg, Germany; Elekta Inc. of 
Atlanta, Georgia; IMPAC Medical Systems, Inc. of Sunnyvale, California; 
Elekta Instrument (Shanghai) Limited of Shanghai, China; and Elekta 
Beijing Medical Systems Co. Ltd. of Beijing, China (collectively, 
``Elekta''). The ALJ also recommended that cease and desist orders be 
directed to Elekta. Parties are to file public interest submissions 
pursuant to 19 CFR 210.50(a)(4).

FOR FURTHER INFORMATION CONTACT: Ron Traud, Office of the General 
Counsel, U.S. International Trade Commission, 500 E Street SW., 
Washington, DC 20436, telephone (202) 205-3427. Copies of non-
confidential documents filed in connection with this investigation, 
including the complaint and the public record, can be accessed on the 
Commission's electronic docket (EDIS) at https://edis.usitc.gov, and 
are or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW., Washington, DC 20436, 
telephone (202) 205-2000. General information concerning the Commission 
may also be obtained by accessing its Internet server (https://www.usitc.gov). Hearing-impaired persons are advised that information 
on this matter can be obtained by contacting the Commission's TDD 
terminal on (202) 205-1810.

SUPPLEMENTARY INFORMATION: Section 337 of the Tariff Act of 1930 
provides that if the Commission finds a violation it shall exclude the 
articles concerned from the United States:

unless, after considering the effect of such exclusion upon the 
public health and welfare, competitive conditions in the United 
States economy, the production of like or directly competitive 
articles in the United States, and United States consumers, it finds 
that such articles should not be excluded from entry.

19 U.S.C. 1337(d)(1). A similar provision applies to cease-and-desist 
orders. 19 U.S.C. 1337(f)(1).
    The Commission is interested in further development of the record 
on the public interest in these investigations. Accordingly, members of 
the public are invited to file, pursuant to 19 CFR 210.50(a)(4), 
submissions of no more than five (5) pages, inclusive of attachments, 
concerning the public interest in light of the administrative law 
judge's recommended determination on remedy and bonding

[[Page 76627]]

issued in this investigation on October 27, 2016. Comments should 
address whether issuance of the limited exclusion order and the cease 
and desist orders (``the recommended remedial orders'') in this 
investigation would affect the public health and welfare in the United 
States, competitive conditions in the United States economy, the 
production of like or directly competitive articles in the United 
States, or United States consumers.
    In particular, the Commission is interested in comments that:
    (i) Explain how the articles potentially subject to the recommended 
remedial orders are used in the United States;
    (ii) identify any public health, safety, or welfare concerns in the 
United States relating to the recommended remedial orders;
    (iii) identify like or directly competitive articles that 
complainant, its licensees, or third parties make in the United States 
which could replace the subject articles if they were to be excluded;
    (iv) indicate whether complainant, complainant's licensees, and/or 
third party suppliers have the capacity to replace the volume of 
articles potentially subject to the recommended remedial orders within 
a commercially reasonable time; and
    (v) explain how the recommended remedial orders would impact 
consumers in the United States.
    Written submissions must be filed no later than by close of 
business on December 12, 2016.
    Persons filing written submissions must file the original document 
electronically on or before the deadlines stated above and submit 8 
true paper copies to the Office of the Secretary by noon the next day 
pursuant to section 210.4(f) of the Commission's Rules of Practice and 
Procedure (19 CFR 210.4(f)). Submissions should refer to the 
investigation number (``Inv. No. 968'') in a prominent place on the 
cover page and/or the first page. (See Handbook for Electronic Filing 
Procedures, https://www.usitc.gov/secretary/fed_reg_notices/rules/handbook_on_electronic_filing.pdf.) Persons with questions regarding 
filing should contact the Secretary ((202) 205-2000).
    Any person desiring to submit a document to the Commission in 
confidence must request confidential treatment. All such requests 
should be directed to the Secretary to the Commission and must include 
a full statement of the reasons why the Commission should grant such 
treatment. See 19 CFR 201.6. Documents for which confidential treatment 
by the Commission is properly sought will be treated accordingly. All 
information, including confidential business information and documents 
for which confidential treatment is properly sought, submitted to the 
Commission for purposes of this Investigation may be disclosed to and 
used: (i) By the Commission, its employees and Offices, and contract 
personnel (a) for developing or maintaining the records of this or a 
related proceeding, or (b) in internal investigations, audits, reviews, 
and evaluations relating to the programs, personnel, and operations of 
the Commission including under 5 U.S.C. appendix 3; or (ii) by U.S. 
government employees and contract personnel, solely for cybersecurity 
purposes (all contract personnel will sign appropriate nondisclosure 
agreements). All nonconfidential written submissions will be available 
for public inspection at the Office of the Secretary and on EDIS.
    This action is taken under the authority of section 337 of the 
Tariff Act of 1930, as amended (19 U.S.C. 1337), and in part 210 of the 
Commission's Rules of Practice and Procedure (19 CFR part 210).


    By order of the Commission.

    Issued: October 31, 2016.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2016-26602 Filed 11-2-16; 8:45 am]
 BILLING CODE 7020-02-P